TABLE 1

Affinities of bombesin, neuromedin B, and various synthetic bombesin analogs with position 11 conformationally restricted substitutions for human BRS-3, GRP, and NMB receptors

Data are calculated from dose-inhibition curves in Figs 2, 3, 4. The affinities of [D-Tyr6,β-Ala11,Phe13,Nle14]Bn(6-14), Bn, and NMB were calculated by a least-squares curve-fitting program (LIGAND). The remaining affinities were calculated using the Cheng-Prusoff equation. All values are means ± S.E.M. from at least three experiments. The structures of these conformationally restricted analogs are shown in Fig. 1.


Peptide No.

Peptide Structure

Ki
hBRS-3/Balb/c 3T3 Cells
hGRP-R/Balb/c 3T3 Cells
hNMB-R/Balb/c 3T3 Cells
nM
1 [d-Tyr6,β-Ala11,Phe13,Nle14]Bn(6-14) 0.82 ± 0.1 0.5 ± 0.04 5.9 ± 0.4
2 [d-Tyr6,(R)-Apa11,Phe13,Nle14]Bn(6-14) 2.8 ± 0.1 151 ± 6 2400 ± 96
3 [d-Tyr6,(S)-Apa11,Phe13,Nle14]Bn(6-14) 8.2 ± 1.1 110 ± 5 4370 ± 150
4 [d-Tyr6,(S)-Apa11-2Cl,Phe13,Nle14]Bn(6-14) 85 ± 7 398 ± 28 5890 ± 385
5 [d-Tyr6,(R)-Apa11-2Cl,Phe13,Nle14]Bn(6-14) 24 ± 1 229 ± 28 6920 ± 350
6 [d-Tyr6,(S)-Apa11-4Cl,Phe13,Nle14]Bn(6-14) 776 ± 134 741 ± 85 1950 ± 337
7 [d-Tyr6,(R)-Apa11-4Cl,Phe13,Nle14]Bn(6-14) 8.2 ± 1.1 1860 ± 69 7200 ± 840
8 [d-Tyr6,(S)-Apa11-3Cl,Phe13,Nle14]Bn(6-14) 15.8 ± 1.1 110 ± 17 831 ± 192
9 [d-Tyr6,(R)-Apa11-3Cl,Phe13,Nle14]Bn(6-14) 107 ± 4 2510 ± 290 > 10,000
10 [d-Tyr6,β-Asp11,Phe13,Nle14]Bn(6-14) 490 ± 50 396 ± 44 427 ± 54
11 [d-Tyr6,β-Asp(BzlAmd)11,Phe13,Nle14]Bn(6-14) 708 ± 61 397 ± 51 646 ± 59
12 [d-Tyr6,β-Dap11,Phe13,Nle14]Bn(6-14) 2.3 ± 0.1 1.0 ± 0.1 43 ± 5
13 [d-Tyr6,Nα-acetyl-Dap11,Phe13,Nle14]Bn(6-14) 15.8 ± 2.9 1.7 ± 0.2 89 ± 4
14 [d-Tyr6,Nα-benzoyl-Dap11,Phe13,Nle14]Bn(6-14) 12.3 ± 1.3 3.1 ± 0.5 55 ± 3
15 [d-Tyr6,β-Ala11,Phe13,β-Dap(Pr)14]Bn(6-14) 2400 ± 138 85 ± 17 > 10,000
Bn Bombesin > 10,000 0.36 ± 0.07 22 ± 0.9
NMB
Neuromedin B
> 10,000
97 ± 11
0.55 ± 0.03